rs372096102

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2

The NM_001330260.2(SCN8A):​c.3356C>T​(p.Pro1119Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,588,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

SCN8A
NM_001330260.2 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 1.52

Publications

1 publications found
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SCN8A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 13
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • cognitive impairment with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile convulsions and choreoathetosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonus, familial, 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PP2
Missense variant in the SCN8A gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 213 curated pathogenic missense variants (we use a threshold of 10). The gene has 45 curated benign missense variants. Gene score misZ: 0.78755 (below the threshold of 3.09). Trascript score misZ: 10.436 (above the threshold of 3.09). GenCC associations: The gene is linked to myoclonus, familial, 2, developmental and epileptic encephalopathy, 13, undetermined early-onset epileptic encephalopathy, benign familial infantile epilepsy, complex neurodevelopmental disorder, seizures, benign familial infantile, 5, cognitive impairment with or without cerebellar ataxia, infantile convulsions and choreoathetosis.
BP4
Computational evidence support a benign effect (MetaRNN=0.044911593).
BS2
High AC in GnomAdExome4 at 49 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN8ANM_001330260.2 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 27 ENST00000627620.5 NP_001317189.1
SCN8ANM_014191.4 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 27 ENST00000354534.11 NP_055006.1
SCN8ANM_001177984.3 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 26 NP_001171455.1
SCN8ANM_001369788.1 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 26 NP_001356717.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN8AENST00000354534.11 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 27 1 NM_014191.4 ENSP00000346534.4
SCN8AENST00000627620.5 linkc.3356C>T p.Pro1119Leu missense_variant Exon 17 of 27 5 NM_001330260.2 ENSP00000487583.2
SCN8AENST00000599343.5 linkc.3389C>T p.Pro1130Leu missense_variant Exon 16 of 26 5 ENSP00000476447.3
SCN8AENST00000355133.7 linkc.3356C>T p.Pro1119Leu missense_variant Exon 16 of 25 1 ENSP00000347255.4

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000341
AC:
49
AN:
1436418
Hom.:
0
Cov.:
31
AF XY:
0.0000338
AC XY:
24
AN XY:
710284
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33118
American (AMR)
AF:
0.00
AC:
0
AN:
43856
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24664
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39318
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5478
European-Non Finnish (NFE)
AF:
0.0000438
AC:
48
AN:
1095968
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41436
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68044
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.0000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Sep 02, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 19, 2015
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Pro1119Leu (CCT>CTT): c.3356 C>T in exon 17 of the SCN8A gene (NM_014191.3) The P1119L missense change in the SCN8A gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. This variant is a semi-conservative amino acid substitution as Proline and Leucine are both uncharged, non-polar residues; however, the removal of a Proline, which has a unique ring structure, may alter the secondary structure of the protein. The variant alters a position between the second and third transmembrane domains that is not conserved across species, and in silico analysis is inconsistent with regard to the effect this variant may have on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Pro1119Leu is a disease-causing mutation or a rare benign variant.The variant is found in INFANT-EPI panel(s).

Inborn genetic diseases Uncertain:1
Jan 10, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3356C>T (p.P1119L) alteration is located in exon 17 (coding exon 16) of the SCN8A gene. This alteration results from a C to T substitution at nucleotide position 3356, causing the proline (P) at amino acid position 1119 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Developmental and epileptic encephalopathy Uncertain:1
Apr 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1119 of the SCN8A protein (p.Pro1119Leu). This variant is present in population databases (rs372096102, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with SCN8A-related conditions. ClinVar contains an entry for this variant (Variation ID: 207112). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SCN8A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Hereditary ataxia Uncertain:1
Jul 23, 2019
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SCN8A-related disorder Uncertain:1
Jan 31, 2023
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The SCN8A c.3356C>T variant is predicted to result in the amino acid substitution p.Pro1119Leu. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.070
T
BayesDel_noAF
Benign
-0.34
CADD
Uncertain
25
DANN
Benign
0.75
DEOGEN2
Benign
0.24
T;.;.;.;.
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.39
FATHMM_MKL
Benign
0.27
N
LIST_S2
Uncertain
0.87
D;D;.;D;D
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.045
T;T;T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
-1.7
N;N;N;.;N
PhyloP100
1.5
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
1.3
N;N;N;.;.
REVEL
Uncertain
0.35
Sift
Benign
0.51
T;T;T;.;.
Sift4G
Benign
0.70
T;T;T;T;T
Vest4
0.078
ClinPred
0.17
T
GERP RS
5.1
Varity_R
0.070
gMVP
0.64
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372096102; hg19: chr12-52163103; API